Logo image of HUT

HUT 8 CORP (HUT) Stock Fundamental Analysis

NASDAQ:HUT - Nasdaq - US44812J1043 - Common Stock - Currency: USD

23.32  -0.48 (-2.02%)

After market: 23.42 +0.1 (+0.43%)

Fundamental Rating

4

HUT gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 283 industry peers in the Software industry. There are concerns on the financial health of HUT while its profitability can be described as average. HUT is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

HUT had negative earnings in the past year.
HUT had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: HUT reported negative net income in multiple years.
HUT had negative operating cash flow in 4 of the past 5 years.
HUT Yearly Net Income VS EBIT VS OCF VS FCFHUT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

HUT's Return On Assets of -3.39% is in line compared to the rest of the industry. HUT outperforms 50.53% of its industry peers.
HUT has a Return On Equity (-5.56%) which is comparable to the rest of the industry.
HUT has a better Return On Invested Capital (6.94%) than 76.33% of its industry peers.
Industry RankSector Rank
ROA -3.39%
ROE -5.56%
ROIC 6.94%
ROA(3y)-12.04%
ROA(5y)-6.62%
ROE(3y)-11.28%
ROE(5y)-6.05%
ROIC(3y)N/A
ROIC(5y)N/A
HUT Yearly ROA, ROE, ROICHUT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

HUT's Profit Margin has improved in the last couple of years.
HUT has a better Operating Margin (94.62%) than 98.23% of its industry peers.
HUT's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 41.94%, HUT is not doing good in the industry: 73.85% of the companies in the same industry are doing better.
HUT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 94.62%
PM (TTM) N/A
GM 41.94%
OM growth 3Y117.45%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y140.24%
GM growth 3Y-3.23%
GM growth 5Y61.09%
HUT Yearly Profit, Operating, Gross MarginsHUT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 -200

3

2. Health

2.1 Basic Checks

HUT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
HUT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for HUT has been increased compared to 5 years ago.
The debt/assets ratio for HUT has been reduced compared to a year ago.
HUT Yearly Shares OutstandingHUT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
HUT Yearly Total Debt VS Total AssetsHUT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 2.66 indicates that HUT is not a great score, but indicates only limited risk for bankruptcy at the moment.
HUT has a Altman-Z score of 2.66. This is comparable to the rest of the industry: HUT outperforms 56.54% of its industry peers.
A Debt/Equity ratio of 0.27 indicates that HUT is not too dependend on debt financing.
HUT has a Debt to Equity ratio (0.27) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Altman-Z 2.66
ROIC/WACC0.62
WACC11.22%
HUT Yearly LT Debt VS Equity VS FCFHUT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

2.3 Liquidity

HUT has a Current Ratio of 1.26. This is a normal value and indicates that HUT is financially healthy and should not expect problems in meeting its short term obligations.
HUT has a Current ratio (1.26) which is in line with its industry peers.
HUT has a Quick Ratio of 1.26. This is a normal value and indicates that HUT is financially healthy and should not expect problems in meeting its short term obligations.
HUT has a Quick ratio of 1.26. This is comparable to the rest of the industry: HUT outperforms 41.34% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.26
HUT Yearly Current Assets VS Current LiabilitesHUT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

5

3. Growth

3.1 Past

The earnings per share for HUT have decreased strongly by -128.68% in the last year.
The Earnings Per Share has been growing by 177.31% on average over the past years. This is a very strong growth
The Revenue has been growing slightly by 4.85% in the past year.
HUT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.59% yearly.
EPS 1Y (TTM)-128.68%
EPS 3YN/A
EPS 5Y177.31%
EPS Q2Q%-148.69%
Revenue 1Y (TTM)4.85%
Revenue growth 3Y-2.32%
Revenue growth 5Y14.59%
Sales Q2Q%-57.48%

3.2 Future

The Earnings Per Share is expected to decrease by -15.09% on average over the next years. This is quite bad
The Revenue is expected to grow by 46.67% on average over the next years. This is a very strong growth
EPS Next Y-90.26%
EPS Next 2Y-15.09%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year65.24%
Revenue Next 2Y89.26%
Revenue Next 3Y46.67%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
HUT Yearly Revenue VS EstimatesHUT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
HUT Yearly EPS VS EstimatesHUT Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2020 2021 2022 2023 2024 2025 2026 0 1 -1

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HUT. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 16.85, the valuation of HUT can be described as correct.
80.57% of the companies in the same industry are more expensive than HUT, based on the Price/Forward Earnings ratio.
HUT's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 35.34.
Industry RankSector Rank
PE N/A
Fwd PE 16.85
HUT Price Earnings VS Forward Price EarningsHUT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

86.57% of the companies in the same industry are more expensive than HUT, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.4
HUT Per share dataHUT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8 10

4.3 Compensation for Growth

HUT's earnings are expected to decrease with -15.09% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-15.09%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

HUT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

HUT 8 CORP

NASDAQ:HUT (8/15/2025, 8:27:28 PM)

After market: 23.42 +0.1 (+0.43%)

23.32

-0.48 (-2.02%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-13 2024-11-13/bmo
Earnings (Next)N/A N/A
Inst Owners57.02%
Inst Owner Change-0.9%
Ins Owners11.17%
Ins Owner Change3.32%
Market Cap2.18B
Analysts80
Price Target21.31 (-8.62%)
Short Float %42.9%
Short Ratio2.58
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-35.91%
Min Revenue beat(2)-52.46%
Max Revenue beat(2)-19.36%
Revenue beat(4)1
Avg Revenue beat(4)-20.92%
Min Revenue beat(4)-52.46%
Max Revenue beat(4)13.76%
Revenue beat(8)2
Avg Revenue beat(8)-9.2%
Revenue beat(12)2
Avg Revenue beat(12)-10.39%
Revenue beat(16)4
Avg Revenue beat(16)-7.24%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 16.85
P/S 16.4
P/FCF N/A
P/OCF N/A
P/B 2.27
P/tB 2.44
EV/EBITDA 14.4
EPS(TTM)-0.71
EYN/A
EPS(NY)1.38
Fwd EY5.93%
FCF(TTM)-3.12
FCFYN/A
OCF(TTM)-0.82
OCFYN/A
SpS1.42
BVpS10.27
TBVpS9.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.39%
ROE -5.56%
ROCE 9.26%
ROIC 6.94%
ROICexc 6.94%
ROICexgc 7.3%
OM 94.62%
PM (TTM) N/A
GM 41.94%
FCFM N/A
ROA(3y)-12.04%
ROA(5y)-6.62%
ROE(3y)-11.28%
ROE(5y)-6.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y19.38%
ROICexcg growth 5YN/A
ROICexc growth 3Y17.42%
ROICexc growth 5YN/A
OM growth 3Y117.45%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y140.24%
GM growth 3Y-3.23%
GM growth 5Y61.09%
F-Score2
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Debt/EBITDA 1.47
Cap/Depr 413.46%
Cap/Sales 161.72%
Interest Coverage 11.33
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.26
Quick Ratio 1.26
Altman-Z 2.66
F-Score2
WACC11.22%
ROIC/WACC0.62
Cap/Depr(3y)141.34%
Cap/Depr(5y)164.49%
Cap/Sales(3y)50.16%
Cap/Sales(5y)42.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-128.68%
EPS 3YN/A
EPS 5Y177.31%
EPS Q2Q%-148.69%
EPS Next Y-90.26%
EPS Next 2Y-15.09%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.85%
Revenue growth 3Y-2.32%
Revenue growth 5Y14.59%
Sales Q2Q%-57.48%
Revenue Next Year65.24%
Revenue Next 2Y89.26%
Revenue Next 3Y46.67%
Revenue Next 5YN/A
EBIT growth 1Y317.63%
EBIT growth 3Y112.41%
EBIT growth 5YN/A
EBIT Next Year-48.77%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-159.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y10.47%
OCF growth 3YN/A
OCF growth 5YN/A